← Back to search

BIOMARIN PHARMACEUTICAL INC.

BMRN · NASDAQ

Pharmaceutical Preparation Manufacturing

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.

ESG Scores

Overall ESG
4.3
Environmental
5.6
Social
3.6
Governance
5.1

Gender Diversity

Female Directors0.2727%
Female Executives0.0746268656716418%
Women in Workforce0.5%
CEO GenderMale